Bristol Myers Squibb (BMY) FCF Payout Ratio Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Cover Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-94.03% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
141.61% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-58.56% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-58.88% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-29.55% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
-29.45% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-18.46% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
128.23% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
128.23% |
| Dec 31, 2025 |
162.33% |
| Sep 30, 2025 |
-8.69% |
| Jun 30, 2025 |
-39.81% |
| Mar 31, 2025 |
56.24% |
| Dec 31, 2024 |
1.41% |
| Sep 30, 2024 |
-14.53% |
| Jun 30, 2024 |
-19.81% |
| Mar 31, 2024 |
6.98% |
| Dec 31, 2023 |
-23.54% |
| Sep 30, 2023 |
-19.48% |
| Jun 30, 2023 |
12,086.90% |
| Mar 31, 2023 |
33.43% |
| Dec 31, 2022 |
31.53% |
| Sep 30, 2022 |
53.76% |
| Jun 30, 2022 |
114.93% |
| Mar 31, 2022 |
9.71% |
| Dec 31, 2021 |
-11.51% |
| Sep 30, 2021 |
-54.60% |
| Jun 30, 2021 |
-98.80% |
| Mar 31, 2021 |
11.93% |
| Dec 31, 2020 |
-3.97% |
| Sep 30, 2020 |
69.47% |
| Jun 30, 2020 |
-34.00% |
| Mar 31, 2020 |
-51.93% |
| Dec 31, 2019 |
73.06% |
| Sep 30, 2019 |
-54.18% |
| Jun 30, 2019 |
-53.42% |
| Mar 31, 2019 |
-19.15% |
| Dec 31, 2018 |
-72.99% |
| Sep 30, 2018 |
40.33% |
| Jun 30, 2018 |
58.19% |
| Mar 31, 2018 |
-39.29% |
| Dec 31, 2017 |
25.00% |
| Sep 30, 2017 |
-26.28% |
| Jun 30, 2017 |
-86.51% |
| Mar 31, 2017 |
184.26% |
| Dec 31, 2016 |
-42.59% |
| Sep 30, 2016 |
-71.88% |
| Jun 30, 2016 |
154.17% |
| Mar 31, 2016 |
-207.27% |
| Dec 31, 2015 |
-34.27% |
| Sep 30, 2015 |
183.68% |
| Jun 30, 2015 |
-1,141.72% |
| Mar 31, 2015 |
4.87% |
| Dec 31, 2014 |
229.14% |
| Sep 30, 2014 |
20.75% |
| Jun 30, 2014 |
55.23% |
| Mar 31, 2014 |
213.51% |
| Dec 31, 2013 |
-43.81% |
| Sep 30, 2013 |
383.72% |
| Jun 30, 2013 |
-27.69% |
| Mar 31, 2013 |
-148.70% |
| Dec 31, 2012 |
117.33% |
| Sep 30, 2012 |
-63.26% |
| Jun 30, 2012 |
1.57% |
| Mar 31, 2012 |
57.60% |
| Dec 31, 2011 |
4.56% |
| Sep 30, 2011 |
-17.79% |
| Jun 30, 2011 |
-2.77% |
| Mar 31, 2011 |
-15.39% |
| Dec 31, 2010 |
-31.51% |
| Sep 30, 2010 |
-11.46% |
